Squarepoint Ops LLC Aprea Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

Shares

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2022 May 16, 2022	SELL	$1.59 - $3.16 $23,659 - $47,020	-14,880 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.87 - $5.58 $42,705 - $83,030	14,880 New	14,880 $43,000
Q1 2021 May 17, 2021	SELL	$4.73 - $8.15 $123,840 - $213,383	-26,182 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.92 - $30.67 $82,710 - $515,593	16,811 Added 179.39%	26,182 $129,000
Q3 2020 Nov 16, 2020	BUY	$21.66 - $38.86 $202,975 - $364,157	9,371 New	9,371 $225,000
Q2 2020 Aug 14, 2020	SELL	$25.47 - $39.69 $207,860 - $323,910	-8,161 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$31.65 - $45.3 $23,547 - $33,703	744 Added 10.03%	8,161 $284,000
Q4 2019 Feb 14, 2020	BUY	$18.94 - $49.53 $140,477 - $367,364	7,417 New	7,417 $340,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,849
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.